Sign In
Buy SNN
$29.36
-0.120 (-0.407%)
At Close: Jun 02, 2026
Smith & Nephew (SNN), HOPCo to Enhance Musculoskeletal Care
02:12pm, Wednesday, 07'th Aug 2024
Smith & Nephew (SNN) announces a collaboration with HOPCo to focus on enhancing solutions for ASC customers, physicians, and patients through the latter's digital health and analytics platforms.
Smith & Nephew jumps on progress with turnaround of hip and knee arm
03:58am, Thursday, 01'st Aug 2024
Shares in Smith & Nephew PLC (LSE:SN) sprang 7.7% higher as the replacement hip and knee specialist reported some encouraging elements in its interim results. Overall, the numbers for the first half
Smith & Nephew shares rise as profit beats market forecast
03:28am, Thursday, 01'st Aug 2024
Smith & Nephew's shares rose 9% on Thursday after the British medical equipment maker's half-year profit beat market forecast, helped by a strong performance in its orthopaedics segment.
Should Value Investors Buy Smith & Nephew SNATS (SNN) Stock?
10:46am, Wednesday, 24'th Jul 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Smith & Nephew's (SNN) CATALYSTEM System Gets FDA Clearance
01:30pm, Wednesday, 17'th Jul 2024
Smith & Nephew (SNN) announces the receipt of FDA clearance for its new CATALYSTEM Primary Hip System, which is intended to address the demands of primary hip surgery.
Activist Cevian has a stake in medical device company Smith & Nephew. How it may help improve margins
09:20am, Saturday, 13'th Jul 2024
British company Smith & Nephew is already a global leader in medical tech. Cevian could help it boost its profitability.
Smith & Nephew's (SNN) 5% Stake Acquired by Cevian Capital
12:20pm, Monday, 08'th Jul 2024
Smith & Nephew (SNN) eyes future growth as Cevian Capital purchases a 5% stake in the company.
Activist Investor Takes Stake In Sports Medicine Player Smith & Nephew, Shares Surge
09:35am, Friday, 05'th Jul 2024
Shares of Smith & Nephew Plc SNN are trading higher on Friday. Smith+Nephew offers a medical technology portfolio across orthopedics, sports medicine, ENT, and advanced wound management.
Smith & Nephew shares surge as activist Cevian Capital reveals 5% stake
09:59am, Thursday, 04'th Jul 2024
Activist investor Cevian Capital on Thursday revealed it has built up a 5% stake in British medical equipment seller Smith & Nephew, causing shares in the struggling FTSE-100 company to surge.
Smith & Nephew jumps as activist Cevian's stake revealed
03:31am, Thursday, 04'th Jul 2024
Shares in Smith & Nephew PLC (LSE:SN) jumped after it was revealed that activist investor Cevian Capital has built a stake in the replacement hip and knee maker. The Swedish hedge fund, which has
U.K. Top 40 Quality Dividend Stocks: Summer 2024
01:25pm, Wednesday, 03'rd Jul 2024
Unfortunately, UK investors have had to suffer weak or negative capital gains in recent years to get those high yields. The good news is that the UK remains an attractive market for dividend investors
Smith & Nephew's (SNN) CORIOGRAPH to Aid Arthroplasty Procedure
02:35pm, Friday, 14'th Jun 2024
Smith & Nephew (SNN) announces the launch of its new CORIOGRAPH Pre-Operative Planning and Modeling Services, exclusively for use with the CORI Surgical System.
Smith & Nephew: Work To Be Done But Still Long-Term Potential
08:38pm, Tuesday, 11'th Jun 2024
Smith & Nephew's share price has increased by 14% since September 2022, indicating undervaluation. The company showed decent top line growth with a 6.4% increase in revenue last year. While the compan
National Bank of Canada FI Has $53,000 Stake in Smith & Nephew plc (NYSE:SNN)
05:04am, Monday, 20'th May 2024
National Bank of Canada FI lifted its position in shares of Smith & Nephew plc (NYSE:SNN – Free Report) by 36.0% in the 4th quarter, according to its most recent Form 13F filing with the Se
Smith & Nephew plc (SNN) Q1 2024 Sales/Trading Statement Call Transcript
03:14pm, Wednesday, 01'st May 2024
Smith & Nephew plc (NYSE:SNN ) Q1 2024 Sales/Trading Statement Conference Call May 1, 2024 3:30 AM ET Company Participants Deepak Nath - Chief Executive Officer John Rogers - Chief Financial Officer C
